J A Dunkel, I F Helund, P B Jacobsen, D Grant, P Walday, H Refsum
{"title":"大鼠灌胃后碘沙醇的吸收和排泄。","authors":"J A Dunkel, I F Helund, P B Jacobsen, D Grant, P Walday, H Refsum","doi":"10.1177/0284185195036s39931","DOIUrl":null,"url":null,"abstract":"<p><p>Absorption and excretion of iodixanol 320 mg I/ml were investigated in rats after intragastric administration of 2.5 g I/kg b.w. Animals were observed for up to 96 hours after treatment, and blood, urine and feces taken at several time-points throughout the experiment. Concentrations of iodixanol in serum and urine were measured by means of reversed-phase high-performance liquid chromatography. Fecal concentrations of iodixanol, based on iodine measurements, were determined by X-ray fluorescence spectrometry. Serial radiographs were obtained and histopathological examination was performed on selected tissues. The results indicate that less than 1% of the intragastric dose of iodixanol is absorbed from the intestine into the blood stream. No adverse clinical signs were observed, and there were no treatment-related histomorphological findings.</p>","PeriodicalId":7159,"journal":{"name":"Acta radiologica. Supplementum","volume":"399 ","pages":"253-7"},"PeriodicalIF":0.0000,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/0284185195036s39931","citationCount":"5","resultStr":"{\"title\":\"Absorption and excretion of iodixanol after intragastric administration to rats.\",\"authors\":\"J A Dunkel, I F Helund, P B Jacobsen, D Grant, P Walday, H Refsum\",\"doi\":\"10.1177/0284185195036s39931\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Absorption and excretion of iodixanol 320 mg I/ml were investigated in rats after intragastric administration of 2.5 g I/kg b.w. Animals were observed for up to 96 hours after treatment, and blood, urine and feces taken at several time-points throughout the experiment. Concentrations of iodixanol in serum and urine were measured by means of reversed-phase high-performance liquid chromatography. Fecal concentrations of iodixanol, based on iodine measurements, were determined by X-ray fluorescence spectrometry. Serial radiographs were obtained and histopathological examination was performed on selected tissues. The results indicate that less than 1% of the intragastric dose of iodixanol is absorbed from the intestine into the blood stream. No adverse clinical signs were observed, and there were no treatment-related histomorphological findings.</p>\",\"PeriodicalId\":7159,\"journal\":{\"name\":\"Acta radiologica. Supplementum\",\"volume\":\"399 \",\"pages\":\"253-7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1995-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1177/0284185195036s39931\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta radiologica. Supplementum\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/0284185195036s39931\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta radiologica. Supplementum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/0284185195036s39931","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
摘要
以2.5 g I/kg b.w灌胃碘沙醇320 mg I/ml后,研究大鼠对碘沙醇的吸收和排泄情况。在给药后观察动物长达96小时,并在实验过程中的多个时间点采集血液、尿液和粪便。采用反相高效液相色谱法测定血清和尿液中碘沙醇的浓度。基于碘的测量,用x射线荧光光谱法测定了粪便中碘二醇的浓度。获得一系列x线片并对选定组织进行组织病理学检查。结果表明,只有不到1%的灌胃剂量的碘沙醇从肠道吸收进入血液。没有观察到不良临床症状,也没有治疗相关的组织形态学发现。
Absorption and excretion of iodixanol after intragastric administration to rats.
Absorption and excretion of iodixanol 320 mg I/ml were investigated in rats after intragastric administration of 2.5 g I/kg b.w. Animals were observed for up to 96 hours after treatment, and blood, urine and feces taken at several time-points throughout the experiment. Concentrations of iodixanol in serum and urine were measured by means of reversed-phase high-performance liquid chromatography. Fecal concentrations of iodixanol, based on iodine measurements, were determined by X-ray fluorescence spectrometry. Serial radiographs were obtained and histopathological examination was performed on selected tissues. The results indicate that less than 1% of the intragastric dose of iodixanol is absorbed from the intestine into the blood stream. No adverse clinical signs were observed, and there were no treatment-related histomorphological findings.